Evidence map›Paper›PMID 36727777›Full record

ArticleJournal of the Chinese Medical Association : JCMA2023

Radiomic features derived from pretherapeutic MRI predict chemoradiation response in locally advanced rectal cancer.

Yen Chou, Szu-Hsiang Peng, Hsuan-Yin Lin, Tien-Li Lan, Jeng-Kae Jiang, Wen-Yih Liang, Yu-Wen Hu, Ling-Wei Wang

Abstract read
In one paragraph

Article in Journal of the Chinese Medical Association : JCMA, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Neoadjuvant therapy and locally advanced cancer diseases.Journal of the Chinese Medical Association : JCMA · 2024
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Yen ChouDepartment of Medical Imaging, Fu Jen Catholic University Hospital, New Taipei City, Taiwan, ROC.
Szu-Hsiang PengDepartment of Medical Imaging, Far Eastern Memorial Hospital, New Taipei City, Taiwan, ROC.
Hsuan-Yin LinDivision of Radiology, Taichung Veterans General Hospital, Taichung, Taiwan, ROC.
Tien-Li LanDivision of Radiation Oncology, Taipei Veterans General Hospital, Taipei, Taiwan, ROC.
Jeng-Kae JiangDivision of Colorectal Surgery, Taipei Veterans General Hospital, Taipei, Taiwan, ROC.
Wen-Yih LiangSchool of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan, ROC.
Yu-Wen HuDivision of Radiation Oncology, Taipei Veterans General Hospital, Taipei, Taiwan, ROC.
Ling-Wei WangDivision of Radiation Oncology, Taipei Veterans General Hospital, Taipei, Taiwan, ROC.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe standard treatment for locally advanced rectal cancer (LARC) is neoadjuvant concurrent chemoradiotherapy (CRT) followed by surgical excision. Current evidence suggests a favorable prognosis for those with pathological complete response (pCR), and surgery may be spared for them. We trained and validated regression models for CRT response prediction with selected radiomic features extracted from pretreatment magnetic resonance (MR) images to recruit potential candidates for this watch-and-wait strategy.

methodsWe retrospectively enrolled patients with LARC who underwent pre-CRT MR imaging between 2010 and 2019. Pathological complete response in surgical specimens after CRT was defined as the ground truth. Quantitative features derived from both unfiltered and filtered images were extracted from manually segmented region of interests on T2-weighted images and selected using variance threshold, univariate statistical tests, and cross-validation least absolute shrinkage and selection operator (Lasso) regression. Finally, a regression model using selected features with high coefficients was optimized and evaluated. Model performance was measured by classification accuracies and area under the receiver operating characteristic (AUROC).

resultsWe extracted 1223 radiomic features from each MRI study of 133 enrolled patients. After tumor excision, 34 (26 %) of 133 patients had pCR in resected specimens. When 25 image-derived features were selected from univariate analysis, classification AUROC was 0.86 and 0.79 with the addition of six clinical features on the hold-out internal validation dataset. When 11 image-derived features were used, the optimized linear regression model had an AUROC value of 0.79 and 0.65 with the addition of six clinical features on the hold-out dataset. Among the radiomic features, texture features including gray level variance, strength, and cluster prominence had the highest coefficient by Lasso regression.

conclusionRadiomic features derived from pretreatment MR images demonstrated promising efficacy in predicting pCR after CRT. However, radiomic features combined with clinical features did not result in remarkable improvement in model performance.

Indexed as

Rectal NeoplasmsChemoradiotherapyHumansMagnetic Resonance ImagingNeoadjuvant TherapyRectumRetrospective Studies

Identifiers

PMID36727777
PMCPMC12755438

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.